The Chris Klug Foundation (CKF) is pleased to announce the winners of the third annual Bounce Back Award, presented by Astellas. The award goes to two transplant recipients who exhibit a great post-transplant quality of life. Winners were chosen by CKF staff and board members from more than 60 incredible nominations from 17 states.
Astellas Farma Brasil (AFB) is among the 20 best medium-sized (100-999 employees) multinational companies to work for across all industries in the country, according to the Great Place to Work® Institute’s latest rankings. In June, AFB was honored by the Institute as one of the top three workplaces in the Brazilian pharmaceutical industry.
Astellas Farma Brasil (AFB) has placed #3 among the best companies to work for in the Brazilian pharmaceutical industry, according to the Great Place to Work® Institute’s latest rankings. The results are based on a survey of hundreds of pharmaceutical industry employees across Brazil.
Astellas has earned CEO Cancer Gold Standard re-accreditation for maintaining a strong commitment to the health of its employees and satisfying the latest, comprehensive requirements of the Gold Standard.
Astellas, in collaboration with the Chris Klug Foundation (CKF), today announced its sponsorship of the third annual Bounce Back Award. Nominations are now being accepted for the award, which will recognize two transplant recipients who exhibit a great post-transplant quality of life, whether it is a career accomplishment, participation in a sport or hobby, or simply leading a fulfilling life with family and loved ones.
Astellas today was recognized as one of the top 20 large companies to work for in the Chicago area by Chicago Tribune. The list, based solely on the results of an employee feedback survey conducted by Workplace Dynamics, LLC, measured several key aspects of workplace culture, including alignment, execution and connection. This marks Astellas’ second appearance on Chicago Tribune’s Top Workplaces list.
Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced that it has been named for the first time to the CDP1 Japan 500 Climate Disclosure Leadership Index (CDLI) in recognition of its perfect score on the disclosure of information related to climate change.
Astellas Pharma today was named one of Working Mother Magazine’s 100 Best Companies in the U.S. for its commitment to establishing a corporate culture supportive of working moms and their families. The 100 Best Companies are in the October/November issue of Working Mother Magazine and on workingmother.com.
Astellas Pharma Inc.today announced that it has been selected for the fourth consecutive year to be included in the FTSE4Good Index Series, one of the world’s premier indices for socially responsible investment.